Patents by Inventor David M Tsai

David M Tsai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Function as a service (FaaS) system enhancements
    Patent number: 11922220
    Abstract: Embodiments of systems, apparatuses and methods provide enhanced function as a service (FaaS) to users, e.g., computer developers and cloud service providers (CSPs). A computing system configured to provide such enhanced FaaS service include one or more controls architectural subsystems, software and orchestration subsystems, network and storage subsystems, and security subsystems. The computing system executes functions in response to events triggered by the users in an execution environment provided by the architectural subsystems, which represent an abstraction of execution management and shield the users from the burden of managing the execution. The software and orchestration subsystems allocate computing resources for the function execution by intelligently spinning up and down containers for function code with decreased instantiation latency and increased execution scalability while maintaining secured execution.
    Type: Grant
    Filed: April 16, 2019
    Date of Patent: March 5, 2024
    Assignee: Intel Corporation
    Inventors: Mohammad R. Haghighat, Kshitij Doshi, Andrew J. Herdrich, Anup Mohan, Ravishankar R. Iyer, Mingqiu Sun, Krishna Bhuyan, Teck Joo Goh, Mohan J. Kumar, Michael Prinke, Michael Lemay, Leeor Peled, Jr-Shian Tsai, David M. Durham, Jeffrey D. Chamberlain, Vadim A. Sukhomlinov, Eric J. Dahlen, Sara Baghsorkhi, Harshad Sane, Areg Melik-Adamyan, Ravi Sahita, Dmitry Yurievich Babokin, Ian M. Steiner, Alexander Bachmutsky, Anil Rao, Mingwei Zhang, Nilesh K. Jain, Amin Firoozshahian, Baiju V. Patel, Wenyong Huang, Yeluri Raghuram
  • Plant extract that inhibits the release of Tumor Necrosis Factor alpha (TNF-alpha)
    Publication number: 20020187208
    Abstract: An extract from the Melothria Indica Lou plant, which has the effect of inhibiting the release of cytokines, including Tumor Necrosis Factor-alpha, by immune response cells, such as macrophages, for the therapeutic treatment of sepsis.
    Type: Application
    Filed: March 4, 2002
    Publication date: December 12, 2002
    Applicant: Ambryx Biotechnology, Inc.
    Inventor: David M. Tsai
  • Plant extract that inhibits the release of tumor necrosis factor alpha (TNF-alpha)
    Patent number: 6352729
    Abstract: An extract from the Melothria Indica Lou plant, which has the effect of inhibiting the release of cytokines, including Tumor Necrosis Factor-alpha, by immune response cells, such as macrophages, for the therapeutic treatment of sepsis.
    Type: Grant
    Filed: October 30, 2000
    Date of Patent: March 5, 2002
    Assignee: Ambryx Biotechnology, Inc.
    Inventor: David M Tsai
  • Remote control animal collar
    Patent number: 4919082
    Abstract: An animal training collar is described which is remotely controlled so that pressure can be applied to the neck of the animal from a remote location by the master. The collar contains a radio receiver and elements for applying pressure to the animal's neck on receipt of the appropriate signal from a transmitter.
    Type: Grant
    Filed: November 22, 1988
    Date of Patent: April 24, 1990
    Inventor: David M. Tsai
  • Remote control animal collar
    Patent number: 4898119
    Abstract: An animal training collar is described which is remotely controlled so that the collar can be tightened or released from a remote location by the master. The collar contains a small electric motor, power source, radio receiver and clutch mechanism for transmitting rotational force to a capstan which winds in leads attached to the collar on receipt of the appropriate signal from a transmitter.
    Type: Grant
    Filed: August 11, 1988
    Date of Patent: February 6, 1990
    Inventor: David M. Tsai